Publication | Closed Access
Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells.
154
Citations
28
References
2009
Year
Chemoprevention StrategyApoptosisCell DeathMtor Inhibitor RapamycinCancer BiologyGliomaTumor BiologyOxidative StressSignaling PathwayCancer Cell BiologyPolyphenolic CompoundAnti-cancer AgentRadiation OncologyCancer ResearchMolecular PathwayResveratrol-induced ApoptosisNeuroprotectionPharmacologyCell BiologyTumor SuppressorMedicine
Resveratrol (trans-3,4', 5-trihydroxystilbene) is a naturally occurring polyphenolic compound that has antiinflammatory, antioxidant, neuroprotective properties and acts as a chemopreventive agent. Resveratrol causes cell cycle arrest and induces apoptotic cell death in various types of cancer cells. In the current studies, the effect of resveratrol on phosphoinositide kinase-3 (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling pathway was examined in human U251 glioma cells. Resveratrol decreased both the expression and phosphorylation of Akt. Inhibitors of PI3K (LY294002) and Akt (SH-6) enhanced resveratrol-induced LDH release and caspase-3 activation. Resveratrol reduced phosphorylation of ribosomal protein S6 and the mTOR inhibitor rapamycin further enhanced resveratrol-induced cell death. These results suggest that the downregulation of PI3K/Akt/mTOR signaling pathways may be an important mediator in resveratrol-induced apoptosis in glioma cells.
| Year | Citations | |
|---|---|---|
Page 1
Page 1